Clinical Trial Update: High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease [NA]

View source ↗

Summary

An update on a clinical trial evaluating a high-dose ritonavir-boosted lopinavir liquid formulation as salvage therapy for protease inhibitor–resistant HIV dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: Lampiris, Harry W., M.D. | Conditions: HIV, AIDS | NA | Status: UNKNOWN